|
Dr. Mueller currently serves as our Executive Vice President Drug Innovation and Realization
and Chief Scientific Officer a position he has held since February 2006. In this role he is responsible for Vertex�s global research initiatives pharmaceutical operations manufacturing and controls. From July 2003 to February 2006. Dr. Mueller was our Chief Scientific Officer and Senior Vice President Drug Discovery and Innovation. Prior to joining Vertex Dr. Mueller was the Senior Vice President Research and Development of Boehringer Ingleheim Pharmaceuticals Inc. with responsibility for the development of all drug candidates in the company�s worldwide portfolio in North America. He led research programs in the areas of immunology inflammatory cardiovascular disease and gene therapy on a global basis. During his time with Boehringer Ingelheim Dr. Mueller oversaw the discovery of numerous development candidates and held several positions in basic research medicinal chemistry and management. Dr. Mueller received both an undergraduate degree and a Ph.D. in chemistry at the Albert Einstein University of Ulm Germany where he also holds a Professorship in Theoretic Organic Chemistry. He completed fellowships in quantum pharmacology at Oxford University and in biophysics at Rochester University. | 